|FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE|
Browse Inventors: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Ramesh Gopalaswamy patentsRecent bibliographic sampling of Ramesh Gopalaswamy patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):
04/12/12 - 20120088778 - Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the receptor for advanced glycated end products (RAGE) and its ligands, such as advanced...
Inventors: Adnan M.m. Mjalli, Robert C. Andrews, Ramesh Gopalaswamy, Anitha Hari, Kwasi S. Avor, Ghassan Qabaja, Xiao-chuan Guo, Suparna Gupta, David R. Jones, Xin Chen (Transtech Pharma, Inc.)
06/17/10 - 20100152170 - Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
The present invention relates to compounds and methods from the treatment of cancer. The invention provides compounds that inhibit Aurora kinase, pharmaceutical compositions comprising compounds that inhibit Aurora kinase, and methods for the treatment of cancer using the compounds of the presentation invention or pharmaceutical compositions comprising compounds of the...
Inventors: Inventors: Adnan M.m. Mjalli, Robert C. Andrews, Ramesh Gopalaswamy, Anitha Hari, Kwasi S. Avor, Ghassan Qabaja, Xiao-chuan Guo, Suparna Gupta, David R. Jones, Xin ChenAdnan M.m. Mjalli, Robert C. Andrews, Ramesh Gopalaswamy, Anitha Hari, Kwasi S. Avor, Ghassan Qabaja, Xiao-chuan Guo, Suparna Gupta, David R. Jones, Xin Chen, Adnan M.m. Mjalli, Brian S. Grella, Govindan Subramanian, Murty N. Arimilli, Ramesh Gopalaswamy, Robert C. Andrews, Stephen Davis, Xiaochuan Guo, Jeff Zhu (Transtech Pharma, Inc.)
10/01/09 - 20090247536 - Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
Embodiments of the present invention provide bissulfonamide compounds that are agonists of GalR1. The present invention further provides compositions comprising bissulfonamide compounds that are agonists of GalR1, and methods of use of such compounds and compositions....
Inventors: Adnan M.m. Mjalli, Bapu Gaddam, Mohan Rao, Muralidhar Bondlela, Ramesh Gopalaswamy, Robert C. Andrews, Stephen Davis, Suvi Simila, Tan Ren
(*May have duplicates - we are upgrading our archive.)
20120088778 - Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
The bibliographic references displayed about Ramesh Gopalaswamy's patents are for a recent sample of Ramesh Gopalaswamy's publicly published patent applications. The inventor/author may have additional bibliographic citations listed at the USPTO.gov. FreshPatents.com is not associated or affiliated in any way with the author/inventor or the United States Patent/Trademark Office but is providing this non-comprehensive sample listing for educational and research purposes using public bibliographic data published and disseminated from the United States Patent/Trademark Office public datafeed. This information is also available for free on the USPTO.gov website. If Ramesh Gopalaswamy filed recent patent applications under another name, spelling or location then those applications could be listed on an alternate page. If no bibliographic references are listed here, it is possible there are no recent filings or there is a technical issue with the listing--in that case, we recommend doing a search on the USPTO.gov website.
Sign up for the FreshPatents.com FREE Keyword Monitor and check for keyword phrases (ie. "RFID" , "wireless", "web development", "fuel cells" etc.)...You will be notified when new patent applications and inventions are published that match your keywords. Also you can save for later research public patent/invention documents using our FREE Organizer. It takes only 30 seconds to sign up or login.